Aethlon Medical Inc AEMD

Healthcare Medical Devices

Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

NDAQ:AEMD - Post by User

Aethlon Medical Inc

<< Previous

Bullboard Posts

Next >>

Post by whytestockson Aug 12, 2024 4:00pm

293 Views

Post# 36175186

The Cancer Battle - How Smaller Companies Are Making Big Adv

JUST IN: $AEMD The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid TumorsVancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - August 12, 2024) - Investorideas.com , a go-to investing platform covering biotech and medical technology issues a snapshot on recent news and developments for the treatment of solid cancer tumors, featuring Aethlon Medical, Inc...AEMD - The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec